Center for Emerging and Neglected Diseases (CEND) @ UC Berkeley facilitates innovative solutions for infectious disease challenges. https://xitter.cf/t.co/G5XYGyJ1oH
Berkeley, CA
Joined April 2013
- Tweets1.9K
- Following307
- Followers603
- Likes215
#CalBigGive is TODAY! Donate to support critical programs at CEND focused on student training, public health initiatives, and impactful translational research.
Donate here: givingday.berkeley.edu/givin…
ALT Graphic featuring Jessica Redmond, 2023 PREP Scholar, and her experience with the program. Orange-purple gradient with swirls in the background.
Paper out on the “Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design.” Go check it out! nature.com/articles/s41467-0…
Annual CEND Symposium registration NOW OPEN! 14th-annual-cend-symposium.e…
Learn more about circadian rhythms in malaria parasites🦟to improving public health outcomes in low- and middle-income settings 🩺
ALT Graphic that reads "Fundamental Mechanisms, Breakthrough Therapies and Beyond" on a background of Ebola virus particles with a beacon of light shining through
We'll be hosting an art show by photographer Herlinde Koelbl herlindekoelbl.com/ in Li Ka Shing - you're all invited to the opening reception, Sep 15 at 2pm!
RIP Harald zur Hausen - The Lancet Infectious Diseases thelancet.com/journals/lanin…
Berkeley SkyDeck's Batch 17 applications JUST OPENED! SkyDeck is an accelerator that offers access to an unparalleled network in Silicon Valley. Those selected will receive $200,000 in investment from the Berkeley SkyDeck Fund. APPLY HERE by Aug 24th: lnkd.in/gMeSMKG
Happy to share our paper with the @OlzmannLab lab came out today, Congrats all!!
sciencedirect.com/science/ar…
#CalBigGive is coming up next Thursday, March 9th. Your donations will allow CEND to continue to help prevent and treat diseases, through student training, public health initiatives and translational research.
Donate here: lnkd.in/d3k6wVAy
Congrats @sanaria_inc and @stephenlhoffman for keeping at it - In Vitro Malaria Sporozoite Production established - a huge leap! the-scientist.com/news-opini…
Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better? thelancet.com/journals/lanin…
Our paper is out today - discovery of approved compounds synergistic with remdesivir! nature.com/articles/s41598-0… Great collaboration with the Stanley lab, funded by fastgrants et al @berkeleyMCB @SKonermann @ScottBiering
Congratulations L&S alumnae!! ls.berkeley.edu/news/three-u…
Great job @Fogarty_NIH @NCDCGeorgia for doing low dose Tb treatment trial improving patients' lives. This kind of trial has no financial incentive and is almost never done -fic.nih.gov/News/GlobalHealt…
CENDUCBerkeley retweeted
First retreat in Molecular Therapeutics @berkeleyMCB. What an amazing group of stellar scientists bridging so many disciplines, all excited about turning fundamental mechanism into new modalities! Thank you @BioEnginuityHub @UCBerkeley for hosting us!
CENDUCBerkeley retweeted
The Call for Applications for the 2023 OWSD-@ElsFoundation Awards for early career women scientists in the developing world is NOW OPEN! This year's awards are in Food security, Agricultural productivity and Sustainable food production. All details at bit.ly/2023OWSDAwards
Hurry -Deadline July 29 - ASTHM Shope fellowship 25k for arbovirus work astmh.org/getmedia/dae86c60-…
Known to be toxic for a century, lead still poisons thousands of Midwestern kids npr.org/sections/health-shot…
Being heard on all-oral therapy for resistant tuberculosis thelancet.com/journals/lanin…
‘You get goosebumps from the data’: hopes rise for new malaria vaccine theguardian.com/global-devel…
